Incontinence and Ostomy Care Products Market to Show Healthy CAGR till 2020

The global incontinence and ostomy care products market is anticipated to register a healthy growth rate over the forecast period (2012 to 2020). It is driven by growing healthcare infrastructure and a rapidly increasing elderly populace. Other factors that influence product demand are the problem of obesity, the prevalence of inflammatory bowel diseases, and the availability of advanced products that treat incontinence. Colorectal cancer is yet another factor which can drive the market for such products in developed economies.

Incontinence is a condition in which a person loses control of the urinary bladder which leads to the involuntary leakage of stools or urine. Urinary and fecal are two major types of incontinence. An ostomy is a surgical opening created in the body to dispose of excrements and other body wastes. Different types of ostomies are olostomy, urostomy, and ileostomy. Emotional distress and social stigmas negatively impact the penetration of incontinence and ostomy care products in the industry. However, effective distribution and marketing of the same can create newer avenues for further market growth.

To get free access on “Incontinence and Ostomy Care Products MarketReportt”: Click here 

The Incontinence And Ostomy Care Products Market is fragmented on the basis of products and regions. Products are bifurcated to incontinence care and ostomy care products. Incontinence care products are further divided into absorbents, incontinence bags, and others. ‘Others’ includes cleaners and urinals, deodorizers, and clamps. Among these, absorbents occupied the largest market share in 2013. This can be attributed to their light weight and expandability.

Ostomy care products are sub-divided into ostomy bags, irrigation products, skin barriers, and deodorants. Ostomy bags comprise continent urostomy bags, continent ileostomy bags, urostomy bags, ileostomy bags, and colostomy bags. Among these, ostomy bags held the largest share in 2013. These bags can collect human waste without hindering the daily routine of the user. They are airtight and can be used during or after surgery. Colostomy bags, a type of ostomy bag, had generated revenues of over USD 1 billion in 2012.

Geographically, the global industry is categorized into North America, Asia Pacific, Europe, and Rest of the World (RoW). North America led the global Incontinence And Ostomy Care Products Market with over 37% revenue shares in 2012. This can be ascribed to widespread patient awareness, the large elderly populace, and a strong technology base.

Europe generated substantial revenues in 2016 on account of favorable reimbursement policies and high investment in healthcare infrastructures. The Asia Pacific can expand at a high growth rate during the forecast period. Social acceptance of these products and a large aging population in China & Japan can contribute to regional market revenues. Other factors that can drive regional demand are steady economic growth and heightened awareness.

Some of the major participants in the Incontinence And Ostomy Care Products Market are Unicharm Corporation, B. Braun Melsungen AG, Coloplast A/S, and Kimberly-Clark Corporation. Mergers and acquisitions are common market expansion strategies adopted by these players. Recently, Coloplast reached an agreement to acquire Comfort Medical for USD 160 million. Comfort Medical manufactures products related to incontinence, ostomy, urology, and wound care. This deal may strengthen the product portfolio of Coloplast significantly. Additionally, Coloplast aims at capitalizing on Comfort’s business model to gain customers via physician referrals and response Ads.

Recent material innovations have led to the introduction of thinner products. Newer types of panty liners, pull-up pant underwears, and advanced underpads are successfully being sold on the internet. According to a report by the World Health Organization (WHO), women form a larger consumer base in this market than men.

Increased uptake of medical cannabis due to high health benefits.

The U.S. medical cannabis market is expected to be valued at USD 19.48 billion by 2024, driven by its numerous medical benefits particularly by patients suffering from cancer, chronic pain, and diabetes. Favorable regulatory environment across numerous states including California and Colorado is expected to fuel the growth of the market over the next few years.

Medical Marijuana Regulation and Safety Act implemented in 2015 permits the cultivation and use of cannabis dispensaries at the state and local level which has been one of the key drivers to fuel the U.S market. The rising number of states receiving approval to utilize cannabis for consumption in medical cases is expected to be one of the crucial factors to upsurge the demand for medical marijuana over the forecast period.

Over the past few decades, there have been several controversies surrounding legalization of cannabis for medical purposes; however, increasing signs of medical benefits received from the consumption of cannabis has resulted in the herb being legalized across various states in the nation. The industry is expected to witness significant growth during the forecast period owing to greater consumer acceptance along with an increasing number of companies entering the market.

The symptoms and conditions that can be treated by the herb include cancer, arthritis, epilepsy, nausea, pain Alzheimer’s disease, anorexia, AIDS, HIV, glaucoma, cachexia, Crohn’s disease, migraines, and multiple sclerosis. Chronic pain accounted for 46% of the U.S. cannabis medical market share in 2016. The ability of medical marijuana to curb pain is expected to gain popularity among patients diagnosed with chronic illnesses and pain.

In 2016, solid edibles segment dominated the U.S market generating revenues worth USD 2.47 billion and is expected to continue dominating the industry over the forecast period. The future product innovation and potential growth are substantial owing to continuous development from the consumption of cannabis-infused products owing to their numerous applications including lotions, bath salts, shampoo, lip balm, toothpaste, coffee pods, baked brownies cookies, candy, confectioneries, beverages, vinegar, and oils.

California is known to be the first state in the U.S. that legalized cannabis for medical purpose. In 2016, California recorded the highest revenue generation and is expected to grow at a CAGR of 13% over the projected period. Over the next few years, the number of state governments is expected to legalize cannabis owing to its numerous benefits which will fuel its growth over the projected period.

Access full report or request for a free sample Click here 

Hexa Research has segmented the U.S. medical cannabis market based on usage, consumption, and state:

Segmentation by usage, 2014 - 2024 (USD Million)

• Chronic Pain
• Arthritis
• A migraine
• Cancer
• Others

Segmentation by consumption, 2014 - 2024 (USD Million)

• Solid Edibles
• Inhalation
• Liquid Edibles
• Topical

Segmentation by state, 2014 - 2024 (USD Million)

• California
• Colorado
• Washington
• Arizona
• Michigan

Key players analyzed

• American Cannabis
• Canopy Growth Corporation
• Greengro Technologies
• Medical Marijuana Inc.
• United Cannabis

Demand for safety needles greater than non-safety ones

The global hypodermic needle market to reach USD 4,238.9 billion by 2024. Implementation of stringent legislation to reduce needlestick injury and increasing awareness related to safety needles among the healthcare provider is expected to drive the hypodermic needle market over the forecast period. Furthermore, increasing awareness of the regular immunizations coupled with increasing preference for regular health check-ups will further escalate the demand for hypodermic needles over the forecast period.

Moreover, rising geriatric population, increasing prevalence of diabetes, improving healthcare hygienic sample withdrawal practices in emerging economies such India, China, and Brazil is projected to propel the demand for hypodermic needle over the forecast period. However, the high cost of automated safety needles and the introduction of needleless delivery mechanisms might restrain the market growth in the forecast period.

Worldwide, needlestick injuries are the primary concern for healthcare providers. In the U.S., every year, approximately, 8 to 10 lac needlestick injuries occur to healthcare workers, and about 1000 of them get contacted with infectious diseases, and 500 to 600 die each year due to these type of injuries. The cost of needlestick injury follow-up in the U.S. per incident is approximately USD 3,000, and around USD 3 billion is spent annually in the U.S. on needlestick injuries. Hence, the increasing occurrence of these type of injuries results in the development of improved and effective safety needles.

Safety engineered devices (SEDs) are categorized into passive and active devices. Passive needles are highly preferred over conventional needles owing to its advantages such as user-friendliness and others. Also, with the implementation of the regulations promoting the use of safety hypodermic needles will further enhance the acceptance of these needles over the forecast period. For instance, World Health Organization (WHO) encourages injection safety worldwide through the Safe Injection Global Network (SIGN).

Exposure to needlestick injuries may cause severe blood-borne diseases such as HIV and Hepatitis. Owing to the increasing occurrence of needlestick injuries, healthcare providers are shifting towards the use of safety hypodermic needles. Furthermore, manufacturers are focusing on developing needles and syringes safety-engineered mechanisms to avoid any injuries. For instance, BD has developed SafetyGlide, Vacutainer Eclipse blood collection needle, and VanishPoint blood collection safety needle. Hence, increasing focus on the development of advanced engineered mechanisms about the needles performance and efficiency will further drive the growth.

Access full report or request for free sample: Click here 

Hexa Research has segmented the global hypodermic needle market based on type, end-use and region:

Segmentation by product type, 2014 - 2024 (USD Million)
• Safety Needle
• Non-safety Needle

Segmentation by end-user, 2014 - 2024 (USD Million)
• Hospitals & Clinic
• Diagnostic Lab
• Homecare

Segmentation by region, 2014 - 2024 (USD Million)
• North America
• Europe
• Asia Pacific
• Central & South America
• Middle East & Africa

Key players analyzed:
• Becton, Dickinson, and Company
• Medtronic
• Retractable Technologies

Teeth Whitening Products Market Size Worth USD 7.40 Billion By 2024

Industry Insights: 

The global teeth whitening products market is expected to reach USD 7.40 billion by 2024. The industry is driven by the mounting consumer demand for clean and white teeth coupled with awareness about oral hygiene. Moreover, 99.2% of the people believe that smile is an important social benefit and growing consumer preference for over the counter products in countries such as Germany, France, UK, India and China are anticipated to drive the growth of the market over the forecast period.

The leading teeth whitening products manufacturing companies are focusing on R&D to enhance its product portfolio and are expanding their presence in the global market by acquiring local players of that region. For instance, in April 2017, Colgate-Palmolive acquired Ciba-Geigy, an India-based teeth whitening brand, to expand its reach towards the rural parts of India. These factors are expected to provide an impetus to the growth of the market over the next coming years.

Whitening toothpaste segment holds the largest share in the market in terms of revenue and is expected to maintain its position over the forecast period. Whitening toothpaste has a major role in oral hygiene maintenance. Unhealthy lifestyle accompanied by consumption of liquor, cola, tobacco and other related products which cause discoloration of the teeth are anticipated to drive the market globally.

Request for free sample Report : Click Here 

Segmentation by type, 2014 - 2024 (USD Million)

• Whitening Toothpaste
• Whitening Stripes & gels
• Others

Segmentation by region, 2014 - 2024 (USD Million)

• North America
• Europe
• Asia Pacific
• Central & South America
• Middle East and Africa

Key players analyzed

• Colgate-Palmolive
• GlaxoSmithKline
• Johnson & Johnson
• Proctor & Gamble
• Unilever

Hernia Repair Market Size To Reach USD 6.60 Billion By 2024 | Hexa Research

The global hernia repair market is expected to reach USD 6.60 billion by 2024. Rigorous research & development activities, growing number of obese patients and high susceptibility of geriatric patients to suffer from hernia are expected to drive the market over the forecast period. Increasing technological sophistication in repair devices and rigorous research and development of the drug-eluting mesh is projected to boost the demand for hernia repair devices and consumables.

Post-operative pain is growing concern post-repair with synthetic mesh. Though the cause of pain varies from patient to patient, a primary reason for pain is inflammation associated with the synthetic mesh. Other chronic illnesses related to the use of implanted mesh are abdominal pain, infection (sepsis), bowel obstruction and adhesion. In spite of increasing technological sophistication in mesh technology, synthetic materials remain the most widely used mesh products for hernia repair especially the polypropylene mesh due to their low cost and easy availability.

                                                        Access full report

The biological mesh is gaining momentum in developed countries especially in the U.S. Biologic mesh development has overcome the problem associated the synthetic mesh including foreign body interaction, chronic inflammation, infection, and stiffness. Presence of favorable reimbursement policies coupled with the well-regulated healthcare insurance and increasing prevalence of an inguinal and ventral hernia in developed economies have rendered increased acceptance of this product.

The above mentioned factors collectively boost demand for overall hernia repair consumables and surgical devices market over the forecast period. Owing to shortcomings of synthetic mesh, manufacturers are working on developing cost-effective and technological advanced mesh. For instance, Ariste Medical is developing drug-eluting mesh. These repair products are anticipated to improve the patient outcomes specifically in vascular procedures including hernia and peripheral bypass hemodialysis processes.

Also, manufacturers are focusing on developing composite or hybrid mesh. The hybrid mesh is a result of the combination of best features of biologic and synthetic mesh. Mesh that combines a minute quantity of synthetic material such as polypropylene and biologic building blocks derived from animal tissue has the property to diminish the hazards of inflammatory reactions along with providing long-term durability. Medtronic and COOK Medical are investing in the development of cost-effective composite mesh. This product may overcome the disadvantages associated with the synthetic mesh such as inflammation, sepsis and abdominal adhesion. These factors render cost advantage over the biologic mesh, which in turn is expected to boost the hernia repair market.

Hexa Research has segmented the global hernia repair market based on product, procedure, and region:

Segmentation by product, 2014 - 2024 (USD Million)
• Consumables
• Surgical Devices

Segmentation by procedure, 2014 - 2024 (USD Million)
• Tension Free
• Open Hernia Repair
• Laparoscopic
                                                      

Segmentation by region, 2014 - 2024 (USD Million)
• North America
• Europe
• Asia Pacific
• Central & South America
• Middle East & Africa
    

Key players analyzed:
• Ethicon, Inc.
• Medtronic
• C. R. Bard

                                                     

Rising demand for clinical and other research applications will boost Ultracentrifuge Market by 2024

The global ultracentrifuge market size estimated to reach USD 32.8 million by 2024 and is expected to be driven by its rising demand for clinical and other research applications. Increasing prevalence of diseases such as HIV and hepatitis has resulted in a growing demand for vaccines, which is expected to bolster growth over the next few years.

The global market is currently influenced by research & development in the fields of pharma, molecular biochemistry, biology and cell biology. The growth of these industries is expected to drive the demand for these products over the next few years.

Technological advancements have resulted in the introduction of various features such as programming, automatic cooling of equipment, variable rotor speed and noise reduction resulting in increasing the demand for ultracentrifuges in numerous applications. However, the high installation cost is expected to hinder the growth of the market.

Of the types of ultracentrifuges manufactured, revenues generated by preparative was highest at USD 17.4 million in 2016. Preparative ultracentrifuges are very popular in molecular biology to separate molecular species by gradient separations.

Click Here to know more market Insight 

On the other hand, molecular biology was the largest application segment accounting for 35.9% of the ultracentrifuge market share in 2016. The growth of the molecular biology, primarily to research on the various diseases and industrial enzymes, is expected to propel the growth of the industry subsequently.

North America dominated the global market accounting for 34.8% of the share in 2016. The region is likely to continue its dominance over the next eight years due to an increasing focus on research & development. Rising number of research institutes in the region is expected to propel the growth of the market over the next few years.

Segmentation by rotor type, 2014 - 2024 (USD Thousand)
• Fixed Angle
• Swinging Bucket Rotor
• Vertical Rotor

Segmentation by application, 2014 - 2024 (USD Thousand)
• Molecular Biology
• Biochemistry
• Cell Biology
• Industrial

Segmentation by region, 2014 - 2024 (USD Thousand)
• North America
• Europe
• Asia Pacific
• Central & South America
• MEA

Key players analyzed
• Beckman Coulter Inc.
• Thermo Fisher Scientific Inc.
• Alfa Wassermann Inc.